Northwest Biotherapeutics, Inc. Financial Ratios — NWBO

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-12,976.28	-1,730.15	-499.27	-360.54	-180.34	-129.69	-143.68	-97.3	-117.88	-2,433.61	490.36	-293.87	-211.53	-306.92	-111.39
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-85.82	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-267,770	-5,675	-6,855.75	-6,955.43	-7,258.65	-12,692.94	-16,142.56	-10,550	-1,173.44	-6,675.45	-5,185.67	-3,902.61	-2,783.39	-4,664.54	-4,178.3
Operating Margin (%)	-267,870	-5,676.81	-6,857.11	-6,956.19	-7,261.87	-12,723.27	-16,273.21	-10,863.35	-1,160.95	-6,708.37	-5,243.98	-3,991.74	-2,873.08	-4,812.45	-4,347.9
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-328,300	-8,720.21	-8,132.14	-9,328.34	-6,598.1	-12,875.44	-21,768.75	-8,687.86	-863.57	-41,039.58	17,823.48	-6,240.76	-3,240.11	-6,062.08	-4,404.86
Profit Margin (%)	-328,300	-8,720.21	-8,132.14	-9,328.34	-6,598.1	-12,875.44	-21,768.75	-8,687.86	-863.57	-41,039.58	17,823.48	-6,240.76	-3,240.11	-6,062.08	-4,365.89
Net Income to Common Margin (%)	-328,300	-8,720.21	-8,132.14	-9,328.34	-6,598.1	-13,781.86	-22,145.54	-12,999.76	-863.57	-41,039.58	17,823.48	-6,240.76	-3,240.11	-6,062.08	-4,365.89
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	6.58	1.7	33.17	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	15	4	1	22	22	32	31	17	18	20	38	26	46	67	65
ST Debt	14	2	1	6	12	29	23	15	7	6	8	16	21	35	43
LT Debt	2	2	- -	15	10	3	9	2	12	13	30	10	25	33	22
Total Debt/EBITDA	-0.57	-0.09	-0.02	-0.21	-0.17	-0.4	-0.58	-0.39	-0.64	-0.23	-0.73	-0.4	-0.85	-1.05	-1.13
Net Debt/EBITDA	-0.57	0.08	0.31	-0.08	- -	-0.32	-0.58	0.12	-0.44	-0.06	-0.33	-0.22	-0.72	-0.94	-0.99
Total Debt/EBIT	-0.57	-0.09	-0.02	-0.21	-0.17	-0.4	-0.57	-0.38	-0.64	-0.23	-0.72	-0.39	-0.82	-1.01	-1.08
Net Debt/EBIT	-0.57	0.08	0.31	-0.08	- -	-0.32	-0.57	0.12	-0.44	-0.06	-0.33	-0.22	-0.7	-0.91	-0.95
EBITDA to Interest Expense	-3.5	-3.26	-65.87	-101.54	-30.39	-20.71	-9.78	-4.4	-9.51	-10.09	-10.4	-10.82	-10.26	-8.3	-6.62
EBITDA-CapEx/Interest Expense	-3.51	-3.26	-65.87	-135.4	-32.02	-22.01	-9.78	-4.42	-9.63	-10.86	-11.6	-11.3	-10.92	-8.43	-6.79
EBIT to Interest Expense	-3.5	-3.26	-65.88	-101.55	-30.41	-20.76	-9.86	-4.53	-9.4	-10.14	-10.52	-11.07	-10.59	-8.56	-6.89
Interest Expense	8	13	1	1	4	4	6	10	3	9	5	6	5	8	9
Common Equity/Total Assets	-24,609.91	-212.32	-52.27	-62.04	-6.6	-50.09	-137.68	-191.18	-423.33	-1,103.22	-308.74	-408.97	-236.04	-353.51	-74.15
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-4.42	-15.42	- -	-114.39	58.62	57.56	-53.69	-6.54	-42.56	-3.91	-35.31	-10.17	-122.53	-121.03	490.19
Long-Term Debt/Total Assets (%)	770.28	24.86	- -	27.02	14.25	5.67	17.41	8.05	108.07	40.8	75.65	33.08	88.88	122.47	27.42
Total Debt/Equity (%)	-29.25	-24.09	-12.45	-61.93	-467.94	-119.67	-66.46	-35.62	-40.02	-5.47	-30.6	-20.49	-69.27	-71.37	-107.54
Total Debt/Capital (%)	-41.33	-31.74	-14.22	-162.67	127.18	608.42	-198.12	-55.32	-66.73	-5.79	-44.09	-25.78	-225.4	-249.34	1,425.71
Total Debt/Total Assets (%)	7,197.17	51.15	6.51	38.42	30.91	59.94	64.26	68.1	169.43	60.36	94.47	83.81	163.5	252.32	79.75
Net Debt to Equity	-29.2	21.61	175.97	-23.7	-1.45	-96.32	-66.21	11.51	-27.41	-1.32	-13.89	-11.37	-58.79	-64.03	-94.56
Net Debt/Capital (%)	-41.24	17.77	63.76	-31.06	-1.48	-2,620.64	-195.93	10.32	-45.08	-1.36	-17.02	-13.38	-173.09	-207.04	3,782.48
EBITDA	-27	-44	-55	-101	-126	-79	-54	-43	-28	-86	-52	-66	-54	-64	-58
EBITDA-CapEx	-27	-44	-55	-135	-133	-84	-54	-44	-29	-93	-58	-69	-57	-65	-59
Operating Income (Loss)	-27	-44	-55	-101	-126	-79	-55	-45	-28	-87	-53	-67	-56	-67	-60

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.68	0.94	0.18	0.34	0.08	- -	0.32	0.01	0.03	0.11	0.06	0.05	0.03	0.03
Current Ratio	- -	0.69	0.95	0.2	0.37	0.1	0.02	0.34	0.07	0.04	0.13	0.07	0.09	0.06	0.06
Quick Ratio	- -	0.68	0.94	0.18	0.34	0.08	- -	0.32	0.01	0.03	0.11	0.06	0.05	0.03	0.04
CFO/Avg Current Liab	-0.38	-0.74	-2.48	-1.15	-1.14	-0.79	-0.44	-0.44	-0.56	-0.15	-0.15	-0.41	-0.63	-1	-0.56
Common Equity/Total Assets	-24,609.91	-212.32	-52.27	-62.04	-6.6	-50.09	-137.68	-191.18	-423.33	-1,103.22	-308.74	-408.97	-236.04	-353.51	-74.15
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-4.42	-15.42	- -	-114.39	58.62	57.56	-53.69	-6.54	-42.56	-3.91	-35.31	-10.17	-122.53	-121.03	490.19
Long-Term Debt/Total Assets (%)	770.28	24.86	- -	27.02	14.25	5.67	17.41	8.05	108.07	40.8	75.65	33.08	88.88	122.47	27.42
Total Debt/Equity (%)	-29.25	-24.09	-12.45	-61.93	-467.94	-119.67	-66.46	-35.62	-40.02	-5.47	-30.6	-20.49	-69.27	-71.37	-107.54
Total Debt/Capital (%)	-41.33	-31.74	-14.22	-162.67	127.18	608.42	-198.12	-55.32	-66.73	-5.79	-44.09	-25.78	-225.4	-249.34	1,425.71
Total Debt/Total Assets (%)	7,197.17	51.15	6.51	38.42	30.91	59.94	64.26	68.1	169.43	60.36	94.47	83.81	163.5	252.32	79.75
CFO/Total Liabilities	-28.07	-96.24	-132.16	-59.66	-105.62	-70.09	-37.94	-48.15	-57.2	-8.11	-23.33	-33.1	-57.28	-47.04	-31.62
CFO/CapEx	-300.14	-734	- -	-1.62	-11.81	-11.27	-4,561.88	-179.2	-88.5	-4.86	-6.37	-18.19	-15.61	-56.23	-29.76
Altman's Z-Score	-2,365.6	-76.44	-34.84	-17.66	-16.68	-25	-27.88	-54.08	-122.36	-83.43	-49.39	-70.84	-76.94	-91.58	-86.03

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	54	83	172	369	307	55	79	110	129	1,269	664	838	829	359	354
- Cash & Cash Equivalents	- -	7	18	13	22	6	- -	22	- -	10	15	7	2	2	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	20	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	15	4	1	22	22	32	31	17	18	20	38	26	46	67	65
Enterprise Value	69	79	155	377	307	80	130	104	147	1,279	687	857	873	424	416
Total Capital	-37	-12	-9	-13	17	5	-16	-30	-27	-343	-86	-102	-20	-27	5
Total Debt/Capital (%)	-41.33	-31.74	-14.22	-162.67	127.18	608.42	-198.12	-55.32	-66.73	-5.79	-44.09	-25.78	-225.4	-249.34	1,425.71
Total Debt / EV	0.22	0.05	0.01	0.06	0.07	0.39	0.24	0.16	0.12	0.02	0.06	0.03	0.05	0.16	0.16
EV/Sales	6,899.84	102.77	191.45	259.44	176.43	129.19	387.76	253.51	60.86	990.83	683.23	509.48	451.66	306.79	301.63
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	34	37	124	317	249	39	58	92	118	1,109	706	797	789	335	331
Diluted Enterprise Value	49	33	107	325	249	64	110	87	136	1,119	728	816	833	401	393
EV per Share	7.39	2.99	3.39	5.47	3.2	0.51	0.4	0.2	0.24	1.54	0.72	0.8	0.74	0.32	0.27
TTM Sales	- -	1	1	1	2	1	- -	- -	2	1	1	2	2	1	1
TTM EBITDA	-27	-44	-55	-101	-126	-79	-54	-43	-28	-86	-52	-66	-54	-64	-58
TTM Operating Income	-27	-44	-55	-101	-126	-79	-55	-45	-28	-87	-53	-67	-56	-67	-60
TTM Cash Flow to Firm	-7	-9	-37	-54	-76	-52	-31	-25	-29	-24	-33	-47	-48	-49	-36
TTM Free Cash Flow to Firm	-7	-9	-37	-20	-69	-47	-31	-25	-29	-17	-27	-44	-45	-48	-35

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.31	-1.61	-3.28	-15.2	-3.41	-0.77	-1.6	-2.69	-3.76	-43.54	-21.85	-15.98	-15.73	-5.99	-7.66
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	69	79	155	377	307	80	130	104	147	1,279	687	857	873	424	416
Low Price	4.96	2.56	3	3.79	3.08	0.32	0.14	0.17	0.18	0.14	0.59	0.39	0.4	0.24	0.17
EV/Sales	6,899.84	102.77	191.45	259.44	176.43	129.19	387.76	253.51	60.86	990.83	683.23	509.48	451.66	306.79	301.63
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.41	- -	- -	- -	- -
Price/Earnings Average	-1.55	-0.88	-1.79	-2.57	-5.02	-1.28	-0.78	-2.04	-6.92	-0.77	6.41	-7.65	-11.83	-6.21	-6.17
Price/Earnings High	-2.55	-3.49	-3.44	-4.65	-8.5	-4.11	-1.6	-3.29	-9.49	-3.44	10.48	-19.83	-19.49	-10.82	-11.59
Price/Earnings Low	-0.89	-0.45	-1.5	-1.66	-2.09	-0.41	-0.46	-1.4	-4.88	-0.19	2.88	-3.74	-7.15	-3.59	-4.08
Price/Book Value	-1.03	-5.15	-17.54	-10.53	-65.6	-2.07	-1.17	-2.33	-2.86	-3.5	-5.35	-6.54	-12.61	-3.8	-5.87
Price/Book Value Average	-1.55	-8.34	-16.71	-11.59	-151.98	-5.84	-1.17	-2.76	-3.48	-1.29	-10.05	-6.6	-11.83	-5.89	-6.58
Price/Book Value High	-2.55	-33.03	-32.05	-20.95	-257.28	-18.84	-2.39	-4.44	-4.77	-5.74	-16.45	-17.1	-19.48	-10.26	-12.35
Price/Book Value Low	-0.89	-4.23	-13.95	-7.46	-63.14	-1.9	-0.68	-1.89	-2.45	-0.32	-4.51	-3.22	-7.15	-3.4	-4.35
Price/Tangible Book Value	-1.03	-5.15	-17.54	-10.53	-65.6	-2.07	-1.17	-2.33	-2.86	-3.48	-5.27	-6.45	-12.25	-3.72	-3.1
Price/Tangible Book Value Average	-1.55	-8.34	-16.71	-11.59	-151.98	-5.84	-1.17	-2.76	-3.48	-1.29	-9.9	-6.5	-11.49	-5.77	-3.48
Price/Tangible Book Value High	-2.55	-33.03	-32.05	-20.95	-257.28	-18.84	-2.39	-4.44	-4.77	-5.71	-16.19	-16.85	-18.93	-10.06	-6.53
Price/Tangible Book Value Low	-0.89	-4.23	-13.95	-7.46	-63.14	-1.9	-0.68	-1.89	-2.45	-0.32	-4.44	-3.17	-6.95	-3.34	-2.3
Price/Sales	3,390.91	47.52	153.15	218	143	62.4	173.46	224.28	49.16	859.37	608.42	473.52	408.63	242.69	240.49
Price/Sales Average	5,097.58	76.92	145.96	239.85	331.3	175.81	173.61	265.38	59.74	317.54	1,142.2	477.42	383.39	376.24	269.53
Price/Sales High	8,383.09	304.64	279.9	433.56	560.84	566.98	354.15	427.2	81.94	1,409.82	1,868.72	1,237.37	631.43	656.17	506.13
Price/Sales Low	2,919.95	38.99	121.87	154.44	137.64	57.05	101.19	181.56	42.14	78.64	512.81	233.11	231.77	217.53	178.07
Price/Cash Flow	-2.31	-1.61	-3.28	-5.81	-3.12	-0.7	-1.6	-2.67	-3.72	-34.57	-15.97	-15.1	-14.72	-5.88	-7.4
Price/Cash Flow Average	-3.47	-2.61	-3.12	-6.39	-7.23	-1.97	-1.6	-3.16	-4.52	-12.77	-29.97	-15.23	-13.81	-9.12	-8.3
Price/Cash Flow High	-5.7	-10.34	-5.99	-11.55	-12.24	-6.35	-3.26	-5.09	-6.2	-56.71	-49.04	-39.46	-22.74	-15.9	-15.58
Price/Cash Flow Low	-1.99	-1.32	-2.61	-4.11	-3	-0.64	-0.93	-2.16	-3.19	-3.16	-13.46	-7.43	-8.35	-5.27	-5.48
Price/Free Cash Flow Average	-3.48	-2.61	-3.12	-16.73	-7.9	-2.16	-1.6	-3.18	-4.57	-16.09	-41.03	-16.11	-14.75	-9.28	-8.59
Price/Free Cash Flow High	-5.72	-10.35	-5.99	-30.24	-13.37	-6.97	-3.26	-5.12	-6.27	-71.42	-67.12	-41.76	-24.3	-16.19	-16.12
Price/Free Cash Flow Low	-1.99	-1.32	-2.61	-10.77	-3.28	-0.7	-0.93	-2.17	-3.22	-3.98	-18.42	-7.87	-8.92	-5.37	-5.67
EV/Sales Average	9,605.84	169.14	181.46	284.87	408.7	289.51	387.96	302.38	72.38	370.93	1,262.77	513.58	425.14	449.63	332.64
EV/Sales High	14,815.16	683.22	367.57	510.32	691.83	842.5	632.48	494.79	96.54	1,620.58	2,051.57	1,312.84	685.65	749.02	585.29
EV/Sales Low	6,153.11	83.53	147.99	185.45	169.82	121.63	289.88	202.71	53.21	97.61	579.43	256.63	265.91	279.87	234.98
EV/EBITDA Average	-3.59	-2.98	-2.65	-4.1	-5.63	-2.28	-2.4	-2.87	-6.17	-5.56	-24.35	-13.16	-15.27	-9.64	-7.96
EV/EBITDA High	-5.53	-12.04	-5.36	-7.34	-9.53	-6.64	-3.92	-4.69	-8.23	-24.28	-39.56	-33.64	-24.63	-16.06	-14.01
EV/EBITDA Low	-2.3	-1.47	-2.16	-2.67	-2.34	-0.96	-1.8	-1.92	-4.53	-1.46	-11.17	-6.58	-9.55	-6	-5.62
EV/EBIT Average	-3.59	-2.98	-2.65	-4.1	-5.63	-2.28	-2.38	-2.78	-6.23	-5.53	-24.08	-12.87	-14.8	-9.34	-7.65
EV/EBIT High	-5.53	-12.04	-5.36	-7.34	-9.53	-6.62	-3.89	-4.55	-8.32	-24.16	-39.12	-32.89	-23.86	-15.56	-13.46
EV/EBIT Low	-2.3	-1.47	-2.16	-2.67	-2.34	-0.96	-1.78	-1.87	-4.58	-1.46	-11.05	-6.43	-9.26	-5.82	-5.4
Last Price	5.76	3.12	3.77	5.35	3.2	0.35	0.24	0.21	0.21	1.53	0.7	0.78	0.71	0.27	0.23
High Price	14.24	20	6.89	10.64	12.55	3.18	0.49	0.4	0.35	2.51	2.15	2.05	1.09	0.73	0.48
Enterprise Value Average	96	131	147	414	711	180	130	125	174	479	1,269	864	821	621	458
Enterprise Value High	148	527	297	742	1,203	525	213	204	233	2,092	2,062	2,210	1,325	1,035	807
Enterprise Value Low	62	64	120	270	295	76	97	84	128	126	582	432	514	387	324

Shares Outstanding	9	27	46	69	96	157	329	523	614	830	948	1,068	1,175	1,329	1,555
Diluted Weighted Avg Shares	6	12	33	59	78	111	243	440	564	725	1,008	1,016	1,119	1,242	1,457
Basic Weighted Avg Shares	6	12	33	59	78	111	243	440	564	725	874	1,016	1,119	1,242	1,457
Revenue per Share	- -	0.07	0.02	0.02	0.02	0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-4.55	-3.73	-1.69	-1.71	-1.62	-0.71	-0.22	-0.1	-0.05	-0.12	-0.06	-0.06	-0.05	-0.05	-0.04
Operating Income per Share	-4.55	-3.73	-1.69	-1.71	-1.63	-0.71	-0.23	-0.1	-0.05	-0.12	-0.06	-0.07	-0.05	-0.05	-0.04
Basic EPS, GAAP	-5.58	-5.72	-2	-2.29	-1.48	-0.77	-0.31	-0.12	-0.04	-0.73	0.21	-0.1	-0.06	-0.07	-0.04
Basic EPS from Cont Ops	-5.58	-5.72	-2	-2.29	-1.48	-0.72	-0.3	-0.08	-0.04	-0.73	0.21	-0.1	-0.06	-0.07	-0.04
Diluted EPS, GAAP	-5.58	-5.72	-2	-2.29	-1.48	-0.77	-0.31	-0.12	-0.04	-0.73	0.18	-0.1	-0.06	-0.07	-0.04
Diluted EPS from Cont Ops	-5.58	-5.72	-2	-2.29	-1.48	-0.72	-0.3	-0.08	-0.04	-0.73	0.18	-0.1	-0.06	-0.07	-0.04
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.5	-1.94	-1.15	-0.92	-1.03	-0.5	-0.15	-0.08	-0.06	-0.04	-0.04	-0.05	-0.05	-0.05	-0.03
Free Cash Flow per Basic Share	-2.51	-1.94	-1.15	-1.49	-1.11	-0.55	-0.15	-0.08	-0.06	-0.05	-0.05	-0.05	-0.05	-0.05	-0.03
Cash & Equivalents per Share	- -	0.28	0.41	0.19	0.23	0.04	- -	0.04	- -	0.01	0.02	0.01	- -	- -	- -
Book Value per Share	-5.59	-0.61	-0.21	-0.51	-0.05	-0.17	-0.2	-0.09	-0.07	-0.44	-0.13	-0.12	-0.06	-0.07	-0.04
Tangible Book Value per Share	-5.59	-0.61	-0.21	-0.51	-0.05	-0.17	-0.2	-0.09	-0.07	-0.44	-0.13	-0.12	-0.06	-0.07	-0.07

Northwest Biotherapeutics, Inc.